U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C10H14ClN
Molecular Weight 183.678
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CHLORPHENTERMINE

SMILES

CC(C)(N)CC1=CC=C(Cl)C=C1

InChI

InChIKey=ZCKAMNXUHHNZLN-UHFFFAOYSA-N
InChI=1S/C10H14ClN/c1-10(2,12)7-8-3-5-9(11)6-4-8/h3-6H,7,12H2,1-2H3

HIDE SMILES / InChI

Description

Chlorphentermine exerts anorectic properties. It is a synthetic amphetamine derivatc claimed to have none of the excitatory effects of the parenit substanice. PRE-SATE (Chlorphentermine HCl) is an effective appetite suppressant with a pattern of pharmacologic action substantially different from those of traditional anorexigenics. In providing dependable appetite control with appreciable loss of bodyweight, PRE-SATE does not significantly increase central nervous system (CNS), cardiorespiratory or metabolic activity.

CNS Activity

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
338.0 nM [Ki]

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
PRE-SATE

Cmax

ValueDoseCo-administeredAnalytePopulation
0.4 μg/mL
100 mg single, oral
CHLORPHENTERMINE plasma
Homo sapiens

AUC

ValueDoseCo-administeredAnalytePopulation
10.6 μg × h/mL
100 mg single, oral
CHLORPHENTERMINE plasma
Homo sapiens

T1/2

ValueDoseCo-administeredAnalytePopulation
41 h
100 mg single, oral
CHLORPHENTERMINE plasma
Homo sapiens

PubMed

Patents

Sample Use Guides

In Vivo Use Guide
Adults: 65 mg (one tablet) taken with or shortly after the first meal of the day.
Route of Administration: Oral
In Vitro Use Guide
In contrast, lymphocytes pre-incubated with 10(-5)M chlorphentermine (CP) for 60 min, then stimulated with Con A for 2 hours in the presence of 10(-5)M CP, exhibit a significantly depressed inositol phosphate formation. In addition, CP also inhibited the activity of phospholipase C (IC50 = 0.58 mM), the enzyme responsible for the formation of inositol phosphates during lymphocyte activation. Further, lymphocytes activated in a manner that bypasses the phosphatidylinositol pathway are not inhibited by 10(-7)M or 10(-9)M CP as are cells activated with Con A.